Colemanite

2.1 Classification of the substance or mixture

2.1.1 Classification of the substance according to Regulation (EC) Nr. 1272/2008 [CLP] No classification 2.1.2 Classification of the substance according to Directive 67/548/CEE No classification COLEMANITE Safety Data Sheet In compliance with Regulation (EC)1907/2006 (REACH) Regulation (EC) 1272/2008 (CLP) Date of Issue 03/03/2011 Revision date 07/05/2015 2.2 Labelling of the substance 2.2.1 Labelling of the substance according to Regulation (EC) Nr. 1272/2008 [CLP] No labelling 2.2.2 Labelling of the substance according to the Directive 67/548/CEE No labelling

Potential health effects

The primary routes of exposure are inhalation, skin and eyes: Inhalation Occasional mild irritation effects to the nose and throat may occur from inhalation of borate dusts at levels greater than 10 mg/m3. Eye contact May irritate the eyes upon contact. Skin contact None known but may irritate the skin upon contact. Ingestion Colemanite is not intended for ingestion. Inorganic borate salts have low acute toxicity. Acute effects (short term) This product may cause mild irritation, redness, tearing and blurred vision to the eyes, and may cause mouth, throat and gastrointestinal tract irritation. It contains small amounts of orpiment and realgar (arsenic sulphides) as contaminant, which have low toxicity. Acute arsenic intoxication usually occur via ingestion, specifically arsenic trioxide, with homicidal or suicidal intent, although there have been reports of unusual cases resulting from occupational or environmental exposure. See section 8 for exposure controls.